Cabergoline
- Product NDC
- 59762-1005
- 11-digit product format
- 597621005
- Labeler code
- 59762
- Product ID
- 59762-1005_754ad7cd-edf5-4792-890d-07f0e4324c07
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cabergoline
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- NDA020664
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2014-09-22
- Substance
- CABERGOLINE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Ergolines [CS], Ergot Derivative [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cabergoline
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CABERGOLINE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LL60K9J05T |
| Rxcui | 199703 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59762-1005-1 | Cabergoline | 8 in 1 BOTTLE | TABLET | 8 | | 11 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59762-1005 | CABERGOLINE TABLET [MYLAN PHARMACEUTICALS INC.] | 9 | Current NDC, Legacy NDC, 1 package rows | 20250528_e497366b-a124-4d7f-bd45-a883c392d4bb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59762-1005-1 | 59762100501 | 8 TABLET in 1 BOTTLE (59762-1005-1) | 8 tablet | 2014-09-22 | 0000-00-00 | No | No | Current |